Clinico-Pathological Study of Prognostic Factors in HER-2 Positive Patients with Breast Cancer

Clinicopathological Characteristics of Breast Cancer: A local Institutional Experience

Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study

RETROSPECTIVE STUDY CORRELATING BETWEEN CLINICAL STAGING, PATHOLOGIC STAGING AND MOLECULAR SUBTYPES OF BREAST CANCER

A RETROSPECTIVE ANALYSIS OF CLINICOPATHOLOGICAL DATA AND OUTCOMES OF HORMONAL POSITIVE HER2 NEGATIVE METASTATIC BREAST CANCER PATIENTS IN CLINICAL ONCOLOGY DEPARTMENT IN AIN SHAM

BONE MARROW MICRO-METASTASES IN CLINICALLY STAGE I-III HER2/NEU POSITIVE BREAST CANCER

The Effect of Neoadjuvant Chemotherapy on Her-2 Status in Her-2 Negative Breast Cancer Patients: A Study on Pathological Response

Prognostic Value of HER2 in Metastatic Colorectal Cancer: A Single Institutional Experience

Impact of Low HER2 Expression on Neoadjuvant Treatment Response in Early Luminal Breast Cancer

Clinical Prognostic Factors in Breast Cancer